{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:44:44Z","timestamp":1793108684182,"version":"4.5.0"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2022,7,1]]},"DOI":"10.1001\/jamaneurol.2022.1269","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T11:33:42Z","timestamp":1653996822000},"page":"672","source":"Crossref","is-referenced-by-count":263,"title":["Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability"],"prefix":"10.1001","volume":"79","author":[{"given":"Marte-Helene","family":"Bj\u00f8rk","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Neurology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Zoega","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia"},{"name":"Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarit K.","family":"Leinonen","sequence":"additional","affiliation":[{"name":"Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Werenberg","family":"Dreier","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"National Centre for Register-Based Research, Department of Economics and Business Economics, Aarhus School of Business and Social Services, Aarhus University, Aarhus, Denmark"},{"name":"Centre for Integrated Register-Based Research, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Furu","sequence":"additional","affiliation":[{"name":"Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Neurology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Gissler","sequence":"additional","affiliation":[{"name":"Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland"},{"name":"Region Stockholm, Academic Primary Health Care Centre, Stockholm, Sweden"},{"name":"Karolinska Institute, Department of Molecular Medicine and Surgery, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3skar","family":"H\u00e1lfd\u00e1narson","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannicke","family":"Igland","sequence":"additional","affiliation":[{"name":"Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway"},{"name":"Department of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelian","family":"Sun","sequence":"additional","affiliation":[{"name":"National Centre for Register-Based Research, Department of Economics and Business Economics, Aarhus School of Business and Social Services, Aarhus University, Aarhus, Denmark"},{"name":"Department of Neurology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"Tomson","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silje","family":"Alvestad","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"National Center for Epilepsy, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Christensen","sequence":"additional","affiliation":[{"name":"National Centre for Register-Based Research, Department of Economics and Business Economics, Aarhus School of Business and Social Services, Aarhus University, Aarhus, Denmark"},{"name":"Department of Neurology, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"noi220027r1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/pds.v29.8","article-title":"Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006-2016: a study in the five Nordic countries, United States, and Australia.","volume":"29","author":"Cohen","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"noi220027r2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010236.pub2","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.","author":"Bromley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"noi220027r4","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1111\/epi.12621","article-title":"SUDEP and epilepsy-related mortality in pregnancy.","volume":"55","author":"Edey","year":"2014","journal-title":"Epilepsia"},{"issue":"7","key":"noi220027r5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017248","article-title":"Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis.","volume":"7","author":"Veroniki","year":"2017","journal-title":"BMJ Open"},{"issue":"2","key":"noi220027r6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/WCO.0000000000000659","article-title":"Teratogenicity of antiepileptic drugs.","volume":"32","author":"Tomson","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"16","key":"noi220027r7","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"issue":"11","key":"noi220027r8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.25570","article-title":"Association of prenatal exposure to valproate and other antiepileptic drugs with intellectual disability and delayed childhood milestones.","volume":"3","author":"Daugaard","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"noi220027r9","doi-asserted-by":"publisher","first-page":"17362","DOI":"10.1038\/s41598-020-74409-x","article-title":"Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France.","volume":"10","author":"Coste","year":"2020","journal-title":"Sci Rep"},{"issue":"24","key":"noi220027r10","doi-asserted-by":"publisher","first-page":"e3232","DOI":"10.1212\/WNL.0000000000010993","article-title":"Antiseizure medication use during pregnancy and risk of ASD and ADHD in children.","volume":"95","author":"Wiggs","year":"2020","journal-title":"Neurology"},{"issue":"7","key":"noi220027r11","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/epi.2015.56.issue-7","article-title":"Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy.","volume":"56","author":"Wood","year":"2015","journal-title":"Epilepsia"},{"issue":"8","key":"noi220027r12","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/epi.12226","article-title":"Exposure to antiepileptic drugs in utero and child development: a prospective population-based study.","volume":"54","author":"Veiby","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"noi220027r13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.6606","article-title":"Association of prenatal exposure to valproate and other antiepileptic drugs with risk for attention-deficit\/hyperactivity disorder in offspring.","volume":"2","author":"Christensen","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"noi220027r14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"issue":"8","key":"noi220027r15","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/epi.v62.8","article-title":"Neurodevelopmental outcomes in children exposed to newer antiseizure medications: a systematic review.","volume":"62","author":"Knight","year":"2021","journal-title":"Epilepsia"},{"issue":"8","key":"noi220027r16","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00415-020-09809-0","article-title":"Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience\u2014a European perspective.","volume":"268","author":"Toledo","year":"2020","journal-title":"J Neurol"},{"key":"noi220027r17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/CLEP.S314959","article-title":"Nordic Health Registry-based research: a review of health care systems and key registries.","volume":"13","author":"Laugesen","year":"2021","journal-title":"Clin Epidemiol"},{"key":"noi220027r18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5324\/nje.v29i1-2.4053","article-title":"A common data model for harmonization in the Nordic Pregnancy Drug Safety Studies (NorPreSS).","volume":"29","author":"Cohen","year":"2021","journal-title":"N Epid."},{"issue":"4","key":"noi220027r19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/archpedi.161.4.326","article-title":"Prenatal and perinatal risk factors for autism: a review and integration of findings.","volume":"161","author":"Kolevzon","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"10","key":"noi220027r20","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/epi.1997.38.issue-10","article-title":"Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy.","volume":"38","author":"Nilsson","year":"1997","journal-title":"Epilepsia"},{"issue":"2","key":"noi220027r24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00787-014-0553-8","article-title":"The increasing prevalence of reported diagnoses of childhood psychiatric disorders: a descriptive multinational comparison.","volume":"24","author":"Atladottir","year":"2015","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"14","key":"noi220027r25","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.18.0960","article-title":"Diagnosing autism spectrum disorder among children in Norway.","volume":"139","author":"Sur\u00e9n","year":"2019","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"12","key":"noi220027r26","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models.","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"12","key":"noi220027r27","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.clinthera.2019.11.003","article-title":"Analyzing missing data in perinatal pharmacoepidemiology research: methodological considerations to limit the risk of bias.","volume":"41","author":"Lupattelli","year":"2019","journal-title":"Clin Ther"},{"issue":"6","key":"noi220027r28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1684\/epd.2019.1105","article-title":"Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy.","volume":"21","author":"Tomson","year":"2019","journal-title":"Epileptic Disord"},{"key":"noi220027r29","doi-asserted-by":"publisher","first-page":"l5657","DOI":"10.1136\/bmj.l5657","article-title":"Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners.","volume":"367","author":"Desai","year":"2019","journal-title":"BMJ"},{"key":"noi220027r30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.reprotox.2015.03.003","article-title":"First trimester exposure to topiramate and the risk of oral clefts in the offspring: a systematic review and meta-analysis.","volume":"53","author":"Alsaad","year":"2015","journal-title":"Reprod Toxicol"},{"issue":"4","key":"noi220027r31","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1212\/WNL.0000000000004857","article-title":"Topiramate use early in pregnancy and the risk of oral clefts: a pregnancy cohort study.","volume":"90","author":"Hernandez-Diaz","year":"2018","journal-title":"Neurology"},{"issue":"11","key":"noi220027r32","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1111\/epi.12758","article-title":"Birth outcomes after prenatal exposure to antiepileptic drugs\u2014a population-based study.","volume":"55","author":"Kilic","year":"2014","journal-title":"Epilepsia"},{"issue":"18","key":"noi220027r33","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1212\/WNL.0000000000003157","article-title":"Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate.","volume":"87","author":"Bromley","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"noi220027r34","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.reprotox.2012.05.038","article-title":"Preliminary findings of the developmental effects of in utero exposure to topiramate.","volume":"34","author":"Rihtman","year":"2012","journal-title":"Reprod Toxicol"},{"issue":"4","key":"noi220027r35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/ene.v27.4","article-title":"Language impairment in children aged 5 and 8 years after antiepileptic drug exposure in utero\u2014the Norwegian Mother and Child Cohort Study.","volume":"27","author":"Husebye","year":"2020","journal-title":"Eur J Neurol"},{"issue":"12","key":"noi220027r36","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1136\/jnnp-2018-318386","article-title":"In utero exposure to antiepileptic drugs is associated with learning disabilities among offspring.","volume":"89","author":"Bech","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2-3","key":"noi220027r37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0890-6238(97)80001-U","article-title":"Linking etiologies in humans and animal models: studies of autism.","volume":"11","author":"Rodier","year":"1997","journal-title":"Reprod Toxicol"},{"issue":"4","key":"noi220027r38","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1212\/WNL.0000000000001182","article-title":"IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study.","volume":"84","author":"Baker","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"noi220027r39","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"issue":"5","key":"noi220027r42","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1111\/obr.2011.12.issue-5","article-title":"Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials.","volume":"12","author":"Kramer","year":"2011","journal-title":"Obes Rev"},{"issue":"2","key":"noi220027r44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1212\/WNL.0000000000002836","article-title":"Autism and epilepsy: a population-based nationwide cohort study.","volume":"87","author":"Sundelin","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"noi220027r45","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00001648-200109000-00006","article-title":"Do pregnant women report use of dispensed medications?","volume":"12","author":"Olesen","year":"2001","journal-title":"Epidemiology"},{"key":"noi220027r3","unstructured":"Knight? MNM, Tuffnell? D, Shakespeare? J, Kenyon? S, Kurinczuk? JJ. Saving Lives, Improving Mothers\u2019 Care\u2014Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2013-15. Accessed April 28, 2022 https:\/\/www.npeu.ox.ac.uk\/mbrrace-uk\/presentations\/saving-lives-improving-mothers-care"},{"key":"noi220027r21","unstructured":"World Health Organization. Anatomical therapeutic chemical classification (ATC). Accessed April 26, 2021. https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/atc-classification"},{"key":"noi220027r22","unstructured":"World Health Organization. Defined daily dose (DDD)\u2014definition and general considerations. Accessed April 19, 2022. https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/about-ddd"},{"key":"noi220027r23","unstructured":"World Health Organization. International Statistical Classification of Diseases, Tenth Revision (ICD-10). World Health Organization; 1992."},{"key":"noi220027r40","unstructured":"Medicines & Healthcare products Regulatory Agency. Antiepileptic drugs: review of safety of use during pregnancy. Accessed April 19, 2022. https:\/\/www.gov.uk\/government\/publications\/public-assesment-report-of-antiepileptic-drugs-review-of-safety-of-use-during-pregnancy\/antiepileptic-drugs-review-of-safety-of-use-during-pregnancy"},{"key":"noi220027r41","unstructured":"European Medicines Agency. Topamax. Published on October 1, 2009. Accessed May 2, 2022.? https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/topamax"},{"key":"noi220027r43","unstructured":"U.S. Food and Drug Administration. FDA Drug Safety Communication: risk of oral clefts in children born to mothers taking Topamax (topiramate). Accessed April 19, 2022. https:\/\/www.pdr.net\/fda-drug-safety-communication\/topamax?druglabelid=947&id=8793#:~:text=FDA%20Drug%20Safety%20Communication%20for%20Topamax%20(topiramate)&text=FDA%20is%20informing%20the%20public,and%20generic%20products)%20during%20pregnancy"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2793003\/jamaneurology_bjrk_2022_oi_220027_1656444956.23113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T01:08:31Z","timestamp":1727312911000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2793003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2022.1269","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}